-
1
Introduction to the Review Series on Myelodysplasia
Published 2025-01-01“…Ferrata Storti Foundation…”
Get full text
Article -
2
Context and timing matters in acute myeloid leukemia: females are the superior hosts
Published 2025-02-01“…Ferrata Storti Foundation…”
Get full text
Article -
3
Efficacy and safety of currently approved and lower starting doses of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukemia: a phase IV s...
Published 2025-01-01“…Ferrata Storti Foundation…”
Get full text
Article -
4
The nuclear factor-κ B inhibitor SN50 enhances the efficacy of B-cell maturation antigen-targeted chimeric antigen receptor T-cell therapy
Published 2025-01-01“…Ferrata Storti Foundation…”
Get full text
Article -
5
Heat exposure and pediatric immune thrombocytopenia in Japan from 2011 to 2022: a nationwide space-time-stratified case-crossover study
Published 2025-01-01“…Ferrata Storti Foundation…”
Get full text
Article -
6
Comment on: FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving CPX-351: a st...
Published 2025-01-01“…Ferrata Storti Foundation…”
Get full text
Article -
7
Sodium-glucose co-transporter-2 inhibitor treatment-associated changes in hemoglobin level in anemic patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative n...
Published 2025-01-01“…Ferrata Storti Foundation…”
Get full text
Article -
8
Very long-term remission with azacitidine in VEXAS syndrome
Published 2025-01-01“…Ferrata Storti Foundation…”
Get full text
Article -
9
Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02)
Published 2025-02-01“…Ferrata Storti Foundation…”
Get full text
Article -
10
H2-K1 protects murine MLL-AF9 leukemia stem cells from natural killer cell-mediated immune surveillance
Published 2025-01-01“…Ferrata Storti Foundation…”
Get full text
Article -
11
Emerging technologies of single-cell multi-omics
Published 2025-02-01“…Ferrata Storti Foundation…”
Get full text
Article -
12
Integrated genomic analysis to reduce chromosomal analysis for the diagnosis of pediatric hematologic malignancies: addressing the shortage of cytogenetic technologists
Published 2025-01-01“…Ferrata Storti Foundation…”
Get full text
Article -
13
Prevalence and mortality trends of hemoglobinopathies in Italy: a nationwide study
Published 2025-01-01“…Ferrata Storti Foundation…”
Get full text
Article -
14
Alessandro Pileri: an enthusiastic pioneer of modern hematology
Published 2025-02-01“…Ferrata Storti Foundation…”
Get full text
Article -
15
Opportunistic bone density assessment using pre-treatment [18F]FDG-PET/CT identifies fracture risk in lymphoma patients undergoing corticosteroid-containing chemotherapy
Published 2025-01-01“…Ferrata Storti Foundation…”
Get full text
Article -
16
Update on long-term outcomes of a cohort of patients with TCF3::HLF positive acute lymphoblastic leukemia treated with blinatumomab and stem cell transplantation
Published 2025-02-01“…Ferrata Storti Foundation…”
Get full text
Article -
17
Response to Comment on: Multimorbidity, comorbidity, frailty, and venous thromboembolism
Published 2025-02-01“…Ferrata Storti Foundation…”
Get full text
Article -
18
Deep immunophenotypic dissection and clinical impact of T cells in the follicular lymphoma microenvironment
Published 2025-02-01“…Ferrata Storti Foundation…”
Get full text
Article -
19
High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children’s Oncology Group AAL...
Published 2025-01-01“…Ferrata Storti Foundation…”
Get full text
Article -
20
New bispecific antibodies in diffuse large B-cell lymphoma
Published 2025-02-01“…Ferrata Storti Foundation…”
Get full text
Article